By Justin Johnson
Jun 19, 2020
Many licensed Colorado marijuana businesses unfortunately experience disputes among their owners. Reasons vary, but almost all of them trigger regulatory issues that must be navigated.
By Amber Lengacher, Elliot Choi
Jun 15, 2020
While often overlooked, the Single Convention has important implications on cannabis reform, including purportedly requiring the US to maintain cannabis on Schedule I of the CSA.
By Michelle Bodian
Jun 10, 2020
As we reflect on hemp industry progress during Hemp Week, let's also take action to move this industry forward with the following vital initiatives...
Jun 1, 2020
The DEA accepted public comments on rules to enhance the cultivation of “marihuana” for research purposes in the US. View the comment from Vicente Sederberg LLP.
By Corey Cox
May 28, 2020
The CBD-based medicine, Epidiolex, was descheduled by the DEA and is no longer a controlled substance. What are the implications of this change and what, if anything, does it mean for CBD products in general?
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.